Company page

Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. (CPRX) is a public company based in the United States, focused on developing and commercializing innovative therapies for rare diseases. With a market capitalization of approximately $3.84 billion, the company aims to address unmet medical needs through its specialized pharmaceutical products.

profileCPRX:NASDAQAI content: aiUpdated June 24, 2026/company/catalyst-pharmaceuticals-inc/c-kj4ahifl
Catalyst Pharmaceuticals, Inc. logo
Ticker
CPRX:NASDAQ
Asset type
Stock
Market cap
$3.84B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD